FDA, Advisers Mull Framework For Waiving Pediatric Cancer Drug Studies

Press/Media

Period	18 May 2022

Media coverage

Title FDA, Advisers Mull Framework For Waiving Pediatric Cancer Drug Studies
Media name/outlet Inside Health Reform
Country/Territory United States
Date 18/05/22
Persons Rochelle Bagatell

Title	FDA, Advisers Mull Framework For Waiving Pediatric Cancer Drug Studies
Media name/outlet	Inside Health Reform
Country/Territory	United States
Date	18/05/22
Persons	Rochelle Bagatell